Gershanik O S
Seccion Enfermedades Extrapiramidales, Centro Neurologico-Hospital Frances, Buenos Aires, Argentina.
Curr Opin Neurol Neurosurg. 1993 Jun;6(3):369-76.
This review covers the major categories of movement disorders secondary to the use of antipsychotic drugs and other pharmacologic agents that interfere with dopaminergic transmission at the basal ganglionic level. In the past year new syndromes were reported, old concepts were either challenged or supported by recent studies, and significant contributions were made in unraveling the complex pathophysiology of these disorders.
本综述涵盖了使用抗精神病药物及其他在基底神经节水平干扰多巴胺能传递的药理剂继发的主要运动障碍类型。在过去一年中，有新的综合征被报道，旧概念受到近期研究的质疑或支持，并且在阐明这些障碍的复杂病理生理学方面取得了重大进展。
